The serum concentration of the advanced glycation end-product N -(carboxymethyl)lysine is increased in uremia: Technical Note
- 1 October 1997
- journal article
- Published by Elsevier in Kidney International
- Vol. 52 (4) , 1064-1067
- https://doi.org/10.1038/ki.1997.429
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPDKidney International, 1997
- Amyloid β2-microglobulin is modified with Nε-(carboxymethyl)lysine in dialysis-related amyloidosisKidney International, 1996
- Role of the Maillard Reaction in Diabetes Mellitus and Diseases of AgingDrugs & Aging, 1996
- Advanced Glycation End Products (AGE)-Modified Proteins and Their Potential Relevance to AtherosclerosisTrends in Cardiovascular Medicine, 1996
- Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.Proceedings of the National Academy of Sciences, 1994
- Advanced Maillard reaction end products are associated with Alzheimer disease pathology.Proceedings of the National Academy of Sciences, 1994
- beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.Journal of Clinical Investigation, 1993
- Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.Journal of Clinical Investigation, 1993
- Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1993
- Accumulation of Maillard reaction products in skin collagen in diabetes and aging.Journal of Clinical Investigation, 1993